Hjem › Blærekreft › California › Sacramento
Kliniske studier for Blærekreft i Sacramento, CA
10 studier for Blærekreft søker deltakere på steder i og rundt Sacramento (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mercy Cancer Center - Sacramento, Sacramento
- Woodland Memorial Hospital, Woodland · 16 mi unna
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RekruttererFase 2
- University of California Davis Comprehensive Cancer Center, Sacramento
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruttererFase 3
- University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RekruttererFase 2
- UC Davis, Sacramento
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekruttererFase 1
- University of California (UC) Davis Comprehensive Cancer Center, Sacramento
Patient-Derived Xenografts to Reduce Cancer Health Disparities
RekruttererObservasjonsstudie
- University of California Davis Comprehensive Cancer Center, Sacramento
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RekruttererFase 3
- University of California Davis Comprehensive Cancer Center, Sacramento
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
RekruttererFase 2/3
- Sutter Health - Sutter Institute for Medical Research, Sacramento
- University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer
RekruttererFase 1
- University of California Davis Comprehensive Cancer Center, Sacramento
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruttererFase 1
- University of California Davis Comprehensive Cancer Center, Sacramento
Blærekreft-studier i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Washington, DC26 studier
- Boston, MA26 studier
- Baltimore, MD24 studier
- Los Angeles, CA24 studier
- St. Louis, MO22 studier
- Seattle, WA21 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
Andre studier i Sacramento
- Ikke-småcellet lungekreft29 studier
- Lungekreft22 studier
- Brystkreft20 studier
- Prostatakreft19 studier
- Metastatisk kreft16 studier
- Akut myelogen leukemi12 studier
- Hjertesvikt12 studier
- Pankreaskreft12 studier
- Kreft (alle typer)11 studier
- Tykktarmskreft11 studier
- Kolorektal kreft10 studier
- Type 2-diabetes9 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.